Cargando…

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection

Antiretroviral therapy has prolonged the lives of people living with human immunodeficiency virus type 1 (HIV-1), transforming the disease into one that can be controlled with lifelong therapy. The search for an HIV-1 vaccine has plagued researchers for more than three decades with little to no succ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allen, Alexander G., Chung, Cheng-Han, Atkins, Andrew, Dampier, Will, Khalili, Kamel, Nonnemacher, Michael R., Wigdahl, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304358/ https://www.ncbi.nlm.nih.gov/pubmed/30619107 http://dx.doi.org/10.3389/fmicb.2018.02940

Ejemplares similares

Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing
por: Sullivan, Neil T., et al.
Publicado: (2020)

Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy
por: Chung, Cheng-Han, et al.
Publicado: (2021)

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy
por: Atkins, Andrew, et al.
Publicado: (2021)

HIV-1 Tat Length: Comparative and Functional Considerations
por: Mele, Anthony R., et al.
Publicado: (2020)

Integrated Human Immunodeficiency Virus Type 1 Sequence in J-Lat 10.6
por: Chung, Cheng-Han, et al.
Publicado: (2020)

Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites
por: Chung, Cheng-Han, et al.
Publicado: (2020)

CCAAT Enhancer Binding Protein and Nuclear Factor of Activated T Cells Regulate HIV-1 LTR via a Novel Conserved Downstream Site in Cells of the Monocyte-Macrophage Lineage
por: Dahiya, Satinder, et al.
Publicado: (2014)

Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants
por: Dampier, Will, et al.
Publicado: (2017)

Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease
por: Maubert, Monique E., et al.
Publicado: (2016)

Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9
por: Allen, Alexander G., et al.
Publicado: (2023)

Immunomodulatory Effects of Non-Thermal Plasma in a Model for Latent HIV-1 Infection: Implications for an HIV-1-Specific Immunotherapy
por: Mohamed, Hager, et al.
Publicado: (2023)

Extracellular HIV-1 Tat Mediates Increased Glutamate in the CNS Leading to Onset of Senescence and Progression of HAND
por: Marino, Jamie, et al.
Publicado: (2020)

Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease
por: Maubert, Monique E., et al.
Publicado: (2017)

Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localization
por: Ferrucci, Adriano, et al.
Publicado: (2011)

Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage
por: Kilareski, Evelyn M, et al.
Publicado: (2009)

Impact of Viral Activators and Epigenetic Regulators on HIV-1 LTRs Containing Naturally Occurring Single Nucleotide Polymorphisms
por: Shah, Sonia, et al.
Publicado: (2015)

Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients
por: Sullivan, Neil T., et al.
Publicado: (2019)

HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients
por: Dampier, Will, et al.
Publicado: (2016)

HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity
por: Nonnemacher, Michael R., et al.
Publicado: (2016)

Defining Differential Genetic Signatures in CXCR4- and the CCR5-Utilizing HIV-1 Co-Linear Sequences
por: Aiamkitsumrit, Benjamas, et al.
Publicado: (2014)

Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I
por: Shah, Sonia, et al.
Publicado: (2014)

Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
por: Mohamed, Hager, et al.
Publicado: (2022)

Mitochondrial Haplogroup Influences Motor Function in Long-Term HIV-1-Infected Individuals
por: Azar, Ashley, et al.
Publicado: (2016)

Impact of Tat Genetic Variation on HIV-1 Disease
por: Li, Luna, et al.
Publicado: (2012)

cAMP Signaling Enhances HIV-1 Long Terminal Repeat (LTR)-directed Transcription and Viral Replication in Bone Marrow Progenitor Cells
por: Banerjee, Anupam, et al.
Publicado: (2017)

Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures
por: Antell, Gregory C., et al.
Publicado: (2016)

Evidence of Divergent Amino Acid Usage in Comparative Analyses of R5- and X4-Associated HIV-1 Vpr Sequences
por: Antell, Gregory C., et al.
Publicado: (2017)

Prolonged Morphine Exposure Induces Increased Firm Adhesion in an in Vitro Model of the Blood–Brain Barrier
por: Strazza, Marianne, et al.
Publicado: (2016)

Roles of neuropathology-associated reactive astrocytes: a systematic review
por: Lawrence, Jill M., et al.
Publicado: (2023)

Impacts of HIV Cure Interventions on Viral Reservoirs in Tissues
por: Denton, Paul W., et al.
Publicado: (2019)

Editorial: Novel Insights Into a Functional HIV Cure
por: Sardo, Luca, et al.
Publicado: (2021)

Editing out HIV: application of gene editing technology to achieve functional cure
por: Xun, Jingna, et al.
Publicado: (2021)

Gut Microbiome Alterations During HIV/SIV Infection: Implications for HIV Cure
por: Crakes, Katti R., et al.
Publicado: (2019)

Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape
por: White, Martyn K., et al.
Publicado: (2016)

584. Investigation of the Association Between Neurocognitive Function and Depression in HIV Infection
por: Mumford, Brigid, et al.
Publicado: (2018)

Effect of μ-opioid agonist DAMGO on surface CXCR4 and HIV-1 replication in TF-1 human bone marrow progenitor cells
por: Strazza, Marianne, et al.
Publicado: (2014)

Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?
por: Kalidasan, V., et al.
Publicado: (2020)

Chronic Low Dose Morphine Does Not Alter Two In Vitro BBB Models
por: Marino, Jamie, et al.
Publicado: (2022)

Towards a Functional Cure of HIV-1: Insight Into the Chromatin Landscape of the Provirus
por: Janssens, Julie, et al.
Publicado: (2021)

Potential Utilization of APOBEC3-Mediated Mutagenesis for an HIV-1 Functional Cure
por: Ikeda, Terumasa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ev4b7dui03t9dbr5r3u4s0ubg